首页> 外文期刊>Pain Studies and Treatment >Nalbuphine versus Dexmedetomidine as an Analgesic Additive to Lidocaine in Intravenous Regional Anesthesia IVRA
【24h】

Nalbuphine versus Dexmedetomidine as an Analgesic Additive to Lidocaine in Intravenous Regional Anesthesia IVRA

机译:纳布啡与右美托咪定在静脉区域麻醉IVRA中作为利多卡因的止痛剂

获取原文
           

摘要

Intravenous Regional Anesthesia (IVRA) is easy to administer and reliable. But delayed onset and lack of postoperative analgesia are the major limitations. Accordingly, many additives have been tried. Dexmedetomidine is a highly selective α-2 adrenoceptor agonist. Addition of dexmedetomidine to lignocaine is effective in decreasing the anesthetic requirements and prolonging the analgesic duration. On the other hand, many theories explain that opioids may exert their peripheral action through peripheral opioid receptors. The aim of the study was to compare the analgesic efficacy of nalbuphine and dexmedetomidine when used separately as adjuvants to lidocaine during IVRA with the effect of lidocaine alone. Sixty adult patients, who were scheduled for surgery of the hand or the forearm under intravenous regional anesthesia, were included in this study. The patients were randomly allocated into three equal groups. The syringes in all groups contained 3 mg/kg of lidocaine 0.5% diluted in 40 ml isotonic saline. Group C: Control group. Group D: Dexmedetomidine group, 1 mic/kg dexmedetomidine diluted was added. Group N: Nalbuphine group, 20 mg nalbuphine was added. Sensory onset time (min) as well as motor block onset time (min) were significantly shorter in Groups N (2.0 ± 1.7) (3.8 ± 2.1) respectively, and D (2.2 ± 1.8) (4.6 ± 2.2) respectively compared to Group C (3.6 ± 1.6) (7.1 ± 1.4) (P < 0.05), with no significant differences between nalbuphine and dexmedetomidine groups. Sensory and motor block recovery times (min) were significantly longer in Groups N (9.6 ± 0.7) (10.3 ± 1.2) and D (8.1 ± 1.1) (9.1 ± 2.1) when compared to Group C (3.4 ± 2.1) (3.7 ± 3.1) (P < 0.05), without significant differences between nalbuphine and dexmedetomidine. Ramsay sedation score was significantly higher (RSS = 2) in 14 patients (70%) in Group D compared to Groups C and N during the first 30 min after the release of tourniquet.
机译:静脉区域麻醉(IVRA)易于管理且可靠。但是起病延迟和术后镇痛缺乏是主要的局限性。因此,已经尝试了许多添加剂。右美托咪定是一种高度选择性的α-2肾上腺素受体激动剂。将右美托咪定添加到利多卡因中可有效减少麻醉需求并延长镇痛持续时间。另一方面,许多理论解释说阿片类药物可能通过外周阿片受体发挥其外周作用。该研究的目的是比较纳布啡和右美托咪定在IVRA期间分别作为利多卡因的佐剂的镇痛效果与单独利多卡因的作用。这项研究包括了60名计划在静脉区域麻醉下进行手或前臂手术的成年患者。将患者随机分为三组。所有组的注射器均含有3 mg / kg的利多卡因0.5%稀释于40 ml等渗盐水中。 C组:对照组。 D组:右美托咪定组,添加1mic / kg稀释的右美托咪定。 N组:纳布啡组,加入20mg纳布啡。与第N组相比,N组(2.0±1.7)(3.8±2.1)和D(2.2±1.8)(4.6±2.2)分别分别明显缩短了感觉发作时间(min)和运动阻滞发作时间(min)。 C(3.6±1.6)(7.1±1.4)(P <0.05),纳布啡和右美托咪定组之间无显着差异。与C组(3.4±2.1)(3.7±)相比,N(9.6±0.7)(10.3±1.2)和D(8.1±1.1)(9.1±2.1)组的感觉和运动阻滞恢复时间(min)明显更长。 3.1)(P <0.05),纳布啡和右美托咪定之间无显着差异。在释放止血带后的最初30分钟内,D组的14位患者(70%)的Ramsay镇静评分显着高于C组和N组(RSS = 2)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号